NEW BRUNSWICK, N.J. - A New Jersey judge overseeing the state's Aredia/Zometa mass tort litigation on May 11 denied reconsideration of her ruling applying Virginia's two-year statute of limitations to a plaintiff's claim that he developed osteonecrosis of the jaw (ONJ) after being injected with Zometa (In Re: Zometa/Aredia, No. 278, Charles Irby v. Novartis Pharmaceuticals Corp., No. MID-L-1815-08 MT, N.J. Super., Middlesex Co.). Subscribers may view the opinion available within the full update.